SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals
2022 · Nature Communications · 156 citations
https://doi.org/10.1038/s41467-022-32389-8
G
Gagandeep Singh
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
108
Papers
3.5K
Citations
23
h-index
40
i10-index
Gagandeep Singh is an academic researcher from University of Queensland. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & Animal Virus Infections Studies. The author has an h-index of 23, co-authored 92 publications.
ORCID: 0000-0001-5848-2741Papers by this author
worksSARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase
2024 · Immunity · 119 citations
https://doi.org/10.1016/j.immuni.2024.01.017
Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients
2023 · Cell Reports Medicine · 49 citations
https://doi.org/10.1016/j.xcrm.2023.101079
Bivalent COVID-19 booster vaccines and the absence of BA.5-specific antibodies
2023 · The Lancet Microbe · 47 citations
https://doi.org/10.1016/s2666-5247(23)00118-0
Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination
2024 · Cell Reports · 30 citations
https://doi.org/10.1016/j.celrep.2024.114922
IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition
2024 · Nature Communications · 23 citations
https://doi.org/10.1038/s41467-023-44211-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat